This study sought to elucidate whether optimization of cardiac glucose oxidation, through treatment with DCA to stimulate PDH activity, could improve the pathological structural remodeling of the heart associated with Tafazzin deficiency observed in BTHS. This evidence concerns the gene PDP1 and hyperinsulinemic hypoglycemia, familial, 4.